Chamber and committees

A decision on Berwick Bank will be taken by Ministers in due course. We cannot comment on a live application. We are aware of the importance of projects being able to apply for Contract for Difference (CfD) Rounds and will take this timing into account in the decision making process, where possible to do so.

Applications relating to the construction and/or operation of a generating station which may require section 36 consent, must be considered on a case-by-case basis in line with any applicable legislation, which includes the Electricity Act 1989, and in some cases, the Electricity Works (Environmental Impact Assessment) (Scotland) Regulations 2017. The benefits and impacts of any proposal, such as they are material to an application, are particular to each case.

The Human Medicines (Amendment) Regulations 2017 allows schools across the United Kingdom, including independent schools, to buy and hold spare adrenaline auto-injector (AAI) devices without the need for a prescription to treat anaphylaxis in schools in emergency situations where a pupil’s own prescribed device is either not working correctly, or is otherwise unavailable.

We published guidance on supporting children and young people with healthcare needs in schools in December 2017. Information on support for pupils at risk of anaphylaxis is covered within Annex B of this guidance.

The Scottish Government provides funding to local authorities through a block grant. It is the responsibility of individual local authorities to manage their own budgets and to allocate the total financial resources available to them, including on providing AAI devices to schools, on the basis of local needs and priorities.

I refer the member to the answer to question S6W-31455 on 4 December 2024. All answers to written Parliamentary Questions are available on the Parliament’s website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

The Scottish Government has not provided any advice to GPs regarding women who have been potentially exposed to diethylstilbestrol (DES).

The regulation for the licensing, safety and efficacy of medicines is reserved to the UK Government and is the responsibility of the Medicines and Healthcare products Regulatory Agency. They are responsible for investigating any safety concerns regarding the licensing of diethylstilbestrol (DES). Scottish Government officials meet regularly with the MHRA to discuss known medicine safety issues and to agree required actions.

The most recent guidance published by the Department of Health, which also applies in Scotland, advises that daughters of individuals exposed to DES in utero are at an increased risk of clear cell cancer of the cervix and vagina but no other forms of cervical cancer and that local arrangements should be made for the follow up of individuals who are DES daughters and have the stigmata of DES exposure. This would usually be via annual colposcopy.

I refer the member to the answer to question S6W-31648 on 4 December 2024. All answers to written Parliamentary Questions are available on the Parliament’s website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

The proposed reforms are about making the determination process more efficient, not less robust. Environmental assessment standards will remain unchanged. Scottish Ministers will continue to consider each proposal on a case-by-case basis, following review of the application information, consultation responses and representations made by members of the public.

Potential impacts on communities, nature and other valued natural assets or cultural heritage are important considerations in the decision-making process.

The provision and improvement of residential rehabilitation services for women and those with childcare responsibilities is one of the key focuses of the Scottish Government’s National Mission to improve and save lives impacted by substance use.

In the context of the Young Patients Family Fund (YPFF), ‘reasonable overnight accommodation’ is defined as the most cost effective accommodation available. Health Boards have flexibility in relation to how much should be provided in each case but the costs provided should be reasonable in the circumstances.

In an effort to ensure claimants don’t routinely have to provide large amounts of money upfront to cover accommodation costs, the YPFF terms and conditions direct claimants to access Health Board visitor accommodation in the first instance. Where this is not available, private accommodation (e.g. hotel) can be booked and the fund’s terms and conditions direct the Health Board to book on behalf of the claimant where this is possible.

I refer the member to the answer to question S6W-31702 on 4 December 2024. All answers to written Parliamentary Questions are available on the Parliament’s website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers